ruling on tirzepatide court decision A federal court in Delaware has dismissed Eli Lilly's lawsuit against Strive Tirzepatide for Medical Weight Loss

Per BNF and BSH guidance: For confirmed deficiency without neurological involvement: 1 mg IM on alternate days for two weeks, then 1 mg every two to three months for maintenance

Unlike pharmaceutical sleep aids that cause next-day drowsiness, cognitive impairment, tolerance, and dependency, DSIP enhances sleep quality without sedative side effects, maintains normal sleep architecture, causes no morning grogginess, develops no tolerance requiring dose escalation, and demonstrates no withdrawal symptoms or addiction potential

& Guizzetti, M

Organized medical history presentation reduces processing delays and minimizes requests for additional information from insurers